Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antifibrinolytic Agents | 20 | 2022 | 249 | 7.080 |
Why?
|
| Tranexamic Acid | 16 | 2022 | 146 | 5.900 |
Why?
|
| Blood Loss, Surgical | 24 | 2022 | 661 | 5.360 |
Why?
|
| Craniosynostoses | 18 | 2022 | 391 | 4.620 |
Why?
|
| Anemia | 17 | 2022 | 1419 | 3.330 |
Why?
|
| Blood Transfusion | 19 | 2022 | 1257 | 2.490 |
Why?
|
| Erythrocyte Transfusion | 9 | 2022 | 537 | 1.840 |
Why?
|
| Postoperative Hemorrhage | 5 | 2019 | 415 | 1.610 |
Why?
|
| Hemostatics | 4 | 2022 | 229 | 1.300 |
Why?
|
| Perioperative Care | 7 | 2022 | 1069 | 1.250 |
Why?
|
| Blood Component Transfusion | 7 | 2022 | 127 | 1.130 |
Why?
|
| Scoliosis | 3 | 2020 | 695 | 1.050 |
Why?
|
| Reconstructive Surgical Procedures | 7 | 2019 | 2115 | 1.020 |
Why?
|
| Craniotomy | 4 | 2019 | 731 | 1.020 |
Why?
|
| Postoperative Complications | 12 | 2019 | 15102 | 1.000 |
Why?
|
| Craniofacial Abnormalities | 3 | 2018 | 320 | 0.950 |
Why?
|
| Intraoperative Complications | 5 | 2018 | 1187 | 0.920 |
Why?
|
| Surgical Procedures, Operative | 5 | 2019 | 1873 | 0.910 |
Why?
|
| Blood Safety | 1 | 2020 | 11 | 0.810 |
Why?
|
| Colorectal Surgery | 1 | 2021 | 115 | 0.710 |
Why?
|
| Clonidine | 1 | 2019 | 163 | 0.710 |
Why?
|
| Thrombelastography | 5 | 2017 | 158 | 0.700 |
Why?
|
| Standard of Care | 1 | 2022 | 522 | 0.690 |
Why?
|
| Hematocrit | 2 | 2017 | 637 | 0.690 |
Why?
|
| Kyphosis | 1 | 2020 | 215 | 0.680 |
Why?
|
| Pediatrics | 5 | 2020 | 3553 | 0.660 |
Why?
|
| Hemorrhage | 9 | 2022 | 3279 | 0.640 |
Why?
|
| Child | 42 | 2022 | 74468 | 0.640 |
Why?
|
| Fibrinolysis | 3 | 2022 | 345 | 0.620 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2016 | 2 | 0.610 |
Why?
|
| Cephalosporins | 1 | 2017 | 218 | 0.600 |
Why?
|
| Spinal Fusion | 3 | 2020 | 1205 | 0.590 |
Why?
|
| Infant | 33 | 2022 | 34569 | 0.560 |
Why?
|
| Neurosurgical Procedures | 3 | 2015 | 2034 | 0.560 |
Why?
|
| Acute Lung Injury | 2 | 2016 | 379 | 0.540 |
Why?
|
| Aprotinin | 1 | 2014 | 89 | 0.500 |
Why?
|
| Skull | 3 | 2020 | 814 | 0.500 |
Why?
|
| Endoscopy | 3 | 2019 | 1756 | 0.500 |
Why?
|
| Hospital Mortality | 3 | 2016 | 5141 | 0.470 |
Why?
|
| Critical Illness | 7 | 2022 | 2529 | 0.420 |
Why?
|
| Child, Preschool | 24 | 2021 | 41198 | 0.420 |
Why?
|
| Length of Stay | 8 | 2022 | 6270 | 0.420 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 666 | 0.410 |
Why?
|
| Platelet Transfusion | 6 | 2022 | 285 | 0.410 |
Why?
|
| Liver Transplantation | 2 | 2022 | 2019 | 0.400 |
Why?
|
| Medical Records | 1 | 2016 | 1423 | 0.400 |
Why?
|
| Humans | 79 | 2022 | 715818 | 0.380 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 3475 | 0.380 |
Why?
|
| Blood Platelets | 1 | 2020 | 2474 | 0.370 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 1133 | 0.360 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2473 | 0.340 |
Why?
|
| Spine | 1 | 2015 | 1111 | 0.340 |
Why?
|
| Gene Duplication | 1 | 2009 | 334 | 0.320 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3163 | 0.320 |
Why?
|
| Plasma | 5 | 2022 | 570 | 0.320 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3280 | 0.320 |
Why?
|
| Hemostasis | 2 | 2018 | 450 | 0.320 |
Why?
|
| Critical Care | 9 | 2022 | 2494 | 0.310 |
Why?
|
| Chromosomes, Human | 1 | 2009 | 475 | 0.300 |
Why?
|
| Infant, Newborn | 13 | 2022 | 24796 | 0.290 |
Why?
|
| Pandemics | 3 | 2020 | 7313 | 0.290 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1582 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2020 | 11201 | 0.280 |
Why?
|
| Treatment Outcome | 15 | 2019 | 62040 | 0.270 |
Why?
|
| Anesthesia | 1 | 2016 | 1515 | 0.270 |
Why?
|
| Laryngeal Masks | 1 | 2005 | 91 | 0.260 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2016 | 133 | 0.260 |
Why?
|
| Genetic Linkage | 2 | 2001 | 2508 | 0.260 |
Why?
|
| Gene Dosage | 1 | 2009 | 1270 | 0.250 |
Why?
|
| Hemoglobins | 2 | 2022 | 1502 | 0.250 |
Why?
|
| Prone Position | 1 | 2005 | 192 | 0.250 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 1276 | 0.240 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2001 | 77 | 0.240 |
Why?
|
| Perioperative Period | 2 | 2022 | 265 | 0.240 |
Why?
|
| General Surgery | 1 | 2014 | 1631 | 0.220 |
Why?
|
| Double-Blind Method | 4 | 2020 | 11945 | 0.220 |
Why?
|
| Adolescent | 16 | 2021 | 85157 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 5 | 2020 | 7446 | 0.220 |
Why?
|
| Female | 39 | 2022 | 377229 | 0.220 |
Why?
|
| Male | 36 | 2021 | 350352 | 0.210 |
Why?
|
| Encephalocele | 1 | 2022 | 141 | 0.210 |
Why?
|
| Blood Donors | 2 | 2020 | 354 | 0.210 |
Why?
|
| Anesthesia, Epidural | 1 | 2003 | 243 | 0.210 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2022 | 194 | 0.210 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 15198 | 0.200 |
Why?
|
| Propensity Score | 2 | 2018 | 1762 | 0.190 |
Why?
|
| Retrospective Studies | 14 | 2022 | 72473 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2001 | 331 | 0.190 |
Why?
|
| Erythrocyte Count | 1 | 2020 | 170 | 0.190 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7960 | 0.190 |
Why?
|
| Centromere | 1 | 2001 | 221 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2022 | 175 | 0.190 |
Why?
|
| Blood Banks | 1 | 2020 | 106 | 0.190 |
Why?
|
| Registries | 5 | 2019 | 8048 | 0.180 |
Why?
|
| Bone Marrow Diseases | 1 | 2001 | 235 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 7095 | 0.180 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2019 | 88 | 0.180 |
Why?
|
| Hematologic Diseases | 2 | 2000 | 490 | 0.180 |
Why?
|
| Adsorption | 1 | 2019 | 203 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1999 | 390 | 0.170 |
Why?
|
| Intraoperative Care | 2 | 2013 | 782 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1999 | 463 | 0.160 |
Why?
|
| Hematinics | 2 | 2018 | 271 | 0.160 |
Why?
|
| Hemodilution | 2 | 2018 | 115 | 0.160 |
Why?
|
| Evidence-Based Medicine | 7 | 2022 | 3683 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 628 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2017 | 7901 | 0.150 |
Why?
|
| Risk Factors | 11 | 2019 | 70879 | 0.150 |
Why?
|
| Half-Life | 1 | 2017 | 674 | 0.150 |
Why?
|
| Hypovolemia | 1 | 2016 | 41 | 0.150 |
Why?
|
| Prospective Studies | 9 | 2021 | 51317 | 0.150 |
Why?
|
| Hydrocephalus | 1 | 2022 | 735 | 0.140 |
Why?
|
| Models, Biological | 1 | 2013 | 9809 | 0.140 |
Why?
|
| International Normalized Ratio | 1 | 2017 | 369 | 0.140 |
Why?
|
| Blood Gas Analysis | 2 | 2014 | 399 | 0.140 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 565 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2019 | 456 | 0.130 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2014 | 40 | 0.130 |
Why?
|
| Platelet Count | 1 | 2017 | 795 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2021 | 977 | 0.130 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 2292 | 0.130 |
Why?
|
| Papilloma | 1 | 2014 | 155 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 961 | 0.120 |
Why?
|
| Translocation, Genetic | 1 | 1999 | 1414 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2020 | 1510 | 0.120 |
Why?
|
| Blood Substitutes | 1 | 2013 | 58 | 0.120 |
Why?
|
| Fibrinogen | 1 | 2016 | 919 | 0.110 |
Why?
|
| Incidence | 4 | 2019 | 20733 | 0.110 |
Why?
|
| Iron | 1 | 2021 | 1735 | 0.110 |
Why?
|
| Pancreas | 1 | 1999 | 1683 | 0.110 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 958 | 0.110 |
Why?
|
| Analgesics | 1 | 2019 | 1022 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1920 | 0.110 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2013 | 131 | 0.100 |
Why?
|
| Airway Management | 1 | 2015 | 315 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2017 | 939 | 0.100 |
Why?
|
| Preoperative Care | 2 | 2020 | 2345 | 0.100 |
Why?
|
| Erythrocytes | 1 | 2020 | 2410 | 0.100 |
Why?
|
| Hypotension | 1 | 2016 | 828 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 1121 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1794 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2222 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3543 | 0.090 |
Why?
|
| Risk Assessment | 5 | 2018 | 23476 | 0.090 |
Why?
|
| Wounds and Injuries | 2 | 2020 | 2415 | 0.090 |
Why?
|
| Lod Score | 2 | 2001 | 617 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2016 | 4273 | 0.090 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1554 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 1498 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 1253 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2016 | 9985 | 0.090 |
Why?
|
| Bone and Bones | 1 | 1999 | 2567 | 0.080 |
Why?
|
| Erythropoietin | 1 | 2013 | 734 | 0.080 |
Why?
|
| Sepsis | 1 | 2022 | 2465 | 0.080 |
Why?
|
| Blood Coagulation Disorders | 2 | 2020 | 339 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2019 | 40032 | 0.080 |
Why?
|
| Genes, Recessive | 2 | 2001 | 660 | 0.080 |
Why?
|
| Anesthesia, General | 2 | 2015 | 1103 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2013 | 1118 | 0.080 |
Why?
|
| United States | 6 | 2021 | 67910 | 0.080 |
Why?
|
| Cross Infection | 1 | 2016 | 1407 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17409 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2019 | 2581 | 0.080 |
Why?
|
| Logistic Models | 3 | 2019 | 13623 | 0.080 |
Why?
|
| Emergencies | 2 | 2020 | 1122 | 0.070 |
Why?
|
| Intensive Care Units | 2 | 2019 | 3451 | 0.070 |
Why?
|
| Syndrome | 3 | 2001 | 3193 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 5030 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13643 | 0.060 |
Why?
|
| Thiopental | 1 | 2002 | 61 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3409 | 0.060 |
Why?
|
| Epidural Space | 1 | 2003 | 133 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12483 | 0.060 |
Why?
|
| Pedigree | 2 | 2001 | 4710 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1418 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15911 | 0.050 |
Why?
|
| Algorithms | 3 | 2018 | 13758 | 0.050 |
Why?
|
| Operative Blood Salvage | 1 | 2020 | 6 | 0.050 |
Why?
|
| Age Factors | 4 | 2019 | 18787 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19537 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2001 | 744 | 0.050 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2001 | 96 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 1477 | 0.050 |
Why?
|
| Abnormalities, Multiple | 2 | 2014 | 1380 | 0.050 |
Why?
|
| Platelet Function Tests | 1 | 2001 | 267 | 0.050 |
Why?
|
| Seizures | 2 | 2022 | 2580 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2001 | 3516 | 0.050 |
Why?
|
| Time Factors | 3 | 2019 | 40887 | 0.050 |
Why?
|
| Italy | 1 | 2021 | 802 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 1 | 2002 | 410 | 0.050 |
Why?
|
| Prevalence | 1 | 2016 | 14912 | 0.040 |
Why?
|
| Neonatology | 1 | 2020 | 102 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 60 | 0.040 |
Why?
|
| Coagulants | 1 | 2018 | 53 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2003 | 1759 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21795 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2013 | 5065 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 9596 | 0.040 |
Why?
|
| Propofol | 1 | 2002 | 565 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 727 | 0.040 |
Why?
|
| Head | 1 | 2022 | 850 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 554 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 1968 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2020 | 3754 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2001 | 780 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2022 | 829 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2001 | 1110 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 507 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 628 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2001 | 985 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2022 | 806 | 0.030 |
Why?
|
| Craniofacial Dysostosis | 1 | 2014 | 76 | 0.030 |
Why?
|
| Gastroenterology | 1 | 2020 | 513 | 0.030 |
Why?
|
| Acrocephalosyndactylia | 1 | 2014 | 86 | 0.030 |
Why?
|
| Haplotypes | 1 | 2001 | 2885 | 0.030 |
Why?
|
| Reoperation | 2 | 2017 | 4177 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 982 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2022 | 1321 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2001 | 3722 | 0.030 |
Why?
|
| Mutation | 2 | 2013 | 29290 | 0.030 |
Why?
|
| North America | 1 | 2017 | 1202 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 1085 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 945 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 20528 | 0.030 |
Why?
|
| Research | 1 | 2022 | 2016 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 418 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 587 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1999 | 2688 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4823 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2744 | 0.030 |
Why?
|
| Pyramidal Tracts | 1 | 2013 | 259 | 0.030 |
Why?
|
| Embolism, Air | 1 | 2010 | 109 | 0.020 |
Why?
|
| Adult | 4 | 2019 | 212279 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2014 | 656 | 0.020 |
Why?
|
| Alleles | 1 | 2001 | 7099 | 0.020 |
Why?
|
| Prognosis | 2 | 2022 | 29007 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 772 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1307 | 0.020 |
Why?
|
| Pain | 1 | 2002 | 4697 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6654 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 1776 | 0.020 |
Why?
|
| Software | 1 | 2001 | 4396 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 715 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 4905 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2018 | 4375 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8075 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 13213 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 27398 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14902 | 0.010 |
Why?
|
| Trypsinogen | 1 | 2000 | 85 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 56228 | 0.010 |
Why?
|
| Paternal Age | 1 | 2000 | 84 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6730 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 9745 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1581 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13215 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2002 | 1928 | 0.010 |
Why?
|
| Boston | 1 | 2010 | 9377 | 0.010 |
Why?
|
| Family Health | 1 | 2000 | 1289 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 11940 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39305 | 0.010 |
Why?
|
| Heterozygote | 1 | 2000 | 2794 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2000 | 6105 | 0.000 |
Why?
|
| Phenotype | 1 | 2000 | 16311 | 0.000 |
Why?
|
| Aged | 1 | 2013 | 162468 | 0.000 |
Why?
|
| Middle Aged | 1 | 2013 | 214666 | 0.000 |
Why?
|
Concepts
(266)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_